Novartis' 2021 access goal: solutions as 'innovative as the science itself'

Novartis has a busy year ahead with drug launches and pre-launch prep for late-stage pipeline products, but at the same time, the company is making an effort to think differently about improving patient access to its existing medicines, an exec said.